Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Annaida Technologies, a Switzerland-based IVF embryo screening technology spinout of EPFL, has obtained more than CHF1m ($1m) in a round led by life science incubator Hemex. State-owned investment bank Zürcher Kantonalbank backed the round alongside Fongit Seed Invest (FSI), Business Angels Switzerland (BAS), Privilège Ventures, Venture Kick and an undisclosed angel investor. The spinout is developing a non-invasive device that employs nuclear magnetic resonance to quantitatively select in-vitro embryos for test-tube pregnancies. IVF embryos are currently chosen through biopsies based…
